Cargando…

Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope

The occurrence of cardiac implantable electronic devices (CIED) infections and related adverse outcomes have an important financial impact on the healthcare system, with hospitalization length of stay (2–3 weeks on average) being the largest cost driver, including the cost of device system extractio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boriani, Giuseppe, Vitolo, Marco, Wright, David Justin, Biffi, Mauro, Brown, Benedict, Tarakji, Khaldoun G, Wilkoff, Bruce L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221050/ https://www.ncbi.nlm.nih.gov/pubmed/34160600 http://dx.doi.org/10.1093/europace/euab126

Ejemplares similares

Antibiotic eluting envelopes: evidence, technology, and defining high-risk populations
por: Callahan, Thomas D, et al.
Publicado: (2021)

849. Reduced CIED Infections with an Antibacterial Envelope: Microbiologic Analysis of the WRAP-IT Study
por: Sohail, Muhammad R, et al.
Publicado: (2019)

Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial
por: Wilkoff, Bruce L., et al.
Publicado: (2020)

Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial
por: Wilkoff, Bruce L., et al.
Publicado: (2020)

Efficacy of antibacterial envelope use in cardiac implantable electronic device infection prevention: insights from real world data
por: Ziacchi, M, et al.
Publicado: (2023)

Risk factors for hematoma in patients undergoing cardiac device procedures: A WRAP-IT trial analysis
por: Tarakji, Khaldoun G., et al.
Publicado: (2022)

Clinical use of antibacterial mesh envelopes in cardiovascular electronic device implantations
por: Hirsh, David S, et al.
Publicado: (2015)

Risk Profiles and Outcomes of Patients Receiving Cardiovascular Implantable Electronic Devices With and Without Antibacterial Envelopes
por: Woodard, David A, et al.
Publicado: (2022)

Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures
por: Deering, Thomas F., et al.
Publicado: (2022)

REducing INFectiOns thRough Cardiac device Envelope: insight from real world data. The REINFORCE project
por: Ziacchi, Matteo, et al.
Publicado: (2023)

Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives
por: Boriani, Giuseppe, et al.
Publicado: (2007)

REINFORCING the clinical utility of an antibacterial envelope to prevent infection following a cardiac implantable electronic device implant procedure
por: Mittal, Suneet
Publicado: (2023)

Therapy and outcomes of cardiac implantable electronic devices infections
por: Perrin, Tilman, et al.
Publicado: (2021)

Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis
por: Blomstrom-Lundqvist, Carina, et al.
Publicado: (2021)

Epidemiology of cardiac implantable electronic device infections: incidence and risk factors
por: Han, Hui-Chen, et al.
Publicado: (2021)

Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis
por: Woodard, David A, et al.
Publicado: (2022)

Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. “Routine Practice” data from the SEARCH MI registry
por: Boriani, Giuseppe, et al.
Publicado: (2012)

Atrial Remodeling: Evolving Concepts
por: Biffi, Mauro, et al.
Publicado: (2003)

Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices
por: Imberti, Jacopo Francesco, et al.
Publicado: (2023)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

Exploring New Frontiers in Asthma Management for Optimal and Economic Outcomes
por: Meltzer, Eli O., et al.
Publicado: (2003)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Regulation of medical devices outside the European Union
por: Lamph, Susan
Publicado: (2012)

How are medical devices regulated in the European Union?
por: French-Mowat, Elaine, et al.
Publicado: (2012)

Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications
por: Heile, Michael, et al.
Publicado: (2018)

Device-related infection in a large tertiary center-Benefit of the antibacterial envelope
por: Hofer, D, et al.
Publicado: (2023)

Cardiac pacing and lead devices management: 25 years of research at EP Europace journal
por: Defaye, Pascal, et al.
Publicado: (2023)

Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
por: Derking, Ronald, et al.
Publicado: (2021)

A systematic review and meta‐analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients
por: Malavasi, Vincenzo Livio, et al.
Publicado: (2022)

The Impact of COVID-19 Pandemic and Lockdown Restrictions on Cardiac Implantable Device Recipients with Remote Monitoring
por: Diemberger, Igor, et al.
Publicado: (2021)

Feasibility of using smartphone app technology in the remote management of heart failure patients with cardiac implantable electronic devices
por: Ziacchi, M, et al.
Publicado: (2023)

Low incidence rate of infections associated with cardiac implantable electronic device procedures in a large real-world patient cohort
por: Imberti, J F, et al.
Publicado: (2023)

An Evidence-Based Approach: The Emerging Role of Renal Protection in Hypertension; A Focus on Clinical and Economic Factors That Impact Formulary Decision Making
por: Rodby, Roger A., et al.
Publicado: (2004)

The nuclear envelope and the architecture of the nuclear periphery
por: Franke, W. W., et al.
Publicado: (1981)

Smartwatch diagnosis of atrial fibrillation in patient with embolic stroke of unknown source: A case report
por: Patel, Divyang, et al.
Publicado: (2021)

Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges
por: Cao, Huiliang, et al.
Publicado: (2022)

Integration of a Smartphone HF-Dedicated App in the Remote Monitoring of Heart Failure Patients with Cardiac Implantable Electronic Devices: Patient Access, Acceptance, and Adherence to Use
por: Ziacchi, Matteo, et al.
Publicado: (2023)

First-in-Human Use of the Next-generation ProtEmbo Cerebral Embolic Protection System During Transcatheter Aortic Valve-in-valve Implantation
por: Jagielak, Dariusz, et al.
Publicado: (2021)

43. Incorporation of Nitroglycerin into Acellular Dermal Matrix Hydrogel to Improve Perfusion to Skin Envelope in Implant-based Breast Reconstruction
por: Grogan, Graham M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ug266usldrutlbp1s77n0qvr0t